These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2319836)

  • 41. First-pass elimination of lidocaine in the rabbit after peroral and rectal route of administration.
    Ritschel WA; Elconin H; Alcorn GJ; Denson DD
    Biopharm Drug Dispos; 1985; 6(3):281-90. PubMed ID: 4041555
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The pharmacokinetics and colonic tissue concentrations of cyclosporine after i.v., oral, and enema administration.
    Sandborn WJ; Strong RM; Forland SC; Chase RE; Cutler RE
    J Clin Pharmacol; 1991 Jan; 31(1):76-80. PubMed ID: 2045532
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bioavailability of intramuscular ciclosporin in the pig.
    Filipponi F; Messori A; Valenza T; Fabbri LP; Falcini F
    Eur Surg Res; 1990; 22(1):14-8. PubMed ID: 2379521
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cyclosporine absorption in two patients with short-bowel syndrome.
    Roberts R; Sketris IS; Abraham I; Givner ML; MacDonald AS
    Drug Intell Clin Pharm; 1988; 22(7-8):570-2. PubMed ID: 3416741
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Very high concentration in intestinal lymph after oral, but not after intravenous, cyclosporine in the rat.
    Albrechtsen D; Helgerud P; Rugstad HE; Dueland S
    Transplantation; 1985 Aug; 40(2):220-2. PubMed ID: 4024244
    [No Abstract]   [Full Text] [Related]  

  • 46. Pharmacokinetics of cyclosporine in the weanling pig.
    Freeman DJ; Lipohar C; Kreeft J; Grant DR
    Transplantation; 1990 Nov; 50(5):892-3. PubMed ID: 2238070
    [No Abstract]   [Full Text] [Related]  

  • 47. Pharmacokinetics of FK 506 following oral administration: a comparison of FK 506 and cyclosporine.
    Venkataramanan R; Jain A; Warty VW; Abu-Elmagd K; Furakawa H; Imventarza O; Fung J; Todo S; Starzl TE
    Transplant Proc; 1991 Feb; 23(1 Pt 2):931-3. PubMed ID: 1703355
    [No Abstract]   [Full Text] [Related]  

  • 48. Study of the bioavailability of different formulations of 8-methoxypsoralen in the dog.
    Monbaliu JG; Belpaire FM; Bogaert MG
    Biopharm Drug Dispos; 1988; 9(1):1-8. PubMed ID: 3342281
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Liposomal formulation eliminates acute toxicity and pump incompatibility of parenteral cyclosporine.
    Gruber SA; Venkataram S; Canafax DM; Cipolle RJ; Bowers L; Elsberry D; McGuiggan M; Hynes PE; Ritz JA; Gould FH
    Pharm Res; 1989 Jul; 6(7):601-7. PubMed ID: 2798309
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cyclosporine pharmacokinetics in cats following topical ocular administration.
    Gregory CR; Hietala SK; Pedersen NC; Gregory TA; Floyd-Hawkins KA; Patz JD
    Transplantation; 1989 Mar; 47(3):516-9. PubMed ID: 2646782
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of administration route on the selective lymphatic delivery of cyclosporin A by lipid-surfactant mixed micelles.
    Takada K; Yoshimura H; Shibata N; Masuda Y; Yoshikawa H; Muranishi S; Yasumura T; Oka T
    J Pharmacobiodyn; 1986 Feb; 9(2):156-60. PubMed ID: 3712214
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of bile on cyclosporine absorption in dogs.
    Venkataramanan R; Perez HD; Schwinghammer T; Burckart GJ; Ptachcinski RJ; Van Thiel DH; Starzl TE
    Res Commun Chem Pathol Pharmacol; 1986 Jul; 53(1):137-40. PubMed ID: 3749608
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetics of two alternative dosage forms for cyclosporine: liposomes and intralipid.
    Venkataram S; Awni WM; Jordan K; Rahman YE
    J Pharm Sci; 1990 Mar; 79(3):216-9. PubMed ID: 2338629
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ocular penetration of cyclosporine A in the rat eye.
    BenEzra D; Maftzir G
    Arch Ophthalmol; 1990 Apr; 108(4):584-7. PubMed ID: 2322161
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The absolute bioavailability of benzimidazole derivative RU-1205 in rats].
    Spasov AA; Smirnova LA; Rashchenko AI; Kuznetsov KA; Anisimova VA
    Eksp Klin Farmakol; 2014; 77(1):17-9. PubMed ID: 24649597
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetic evaluation of noreximide in rats.
    Koch HP; Pischek G; Holzbecher M; Ritschel WA
    Biopharm Drug Dispos; 1981; 2(3):245-53. PubMed ID: 7295881
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cyclosporine A.
    Gupta AK; Ellis CN; Goldfarb MT; Cooper KD; Rocher L; Brown MD; Baadsgaard O; Voorhees JJ
    Clin Dermatol; 1989; 7(3):98-110. PubMed ID: 2680025
    [No Abstract]   [Full Text] [Related]  

  • 58. Anaphylactic reaction to intravenous cyclosporine.
    Chapuis B; Helg C; Jeannet M; Zulian G; Huber P; Gumovski P
    N Engl J Med; 1985 May; 312(19):1259. PubMed ID: 3990720
    [No Abstract]   [Full Text] [Related]  

  • 59. [Clinical application and significance of drug delivery systems. An immunosuppressant, cyclosporin A].
    Takada K
    Nihon Rinsho; 1989 Jun; 47(6):1308-15. PubMed ID: 2769992
    [No Abstract]   [Full Text] [Related]  

  • 60. Absence of allergic reaction to cyclosporin capsules in patient allergic to standard oral and intravenous solution of cyclosporin.
    van Hooff JP; Bessems P; Beuman GH; Leunissen KM
    Lancet; 1987 Dec; 2(8573):1456. PubMed ID: 2892007
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.